DCK


Summary: Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location
OMIM IDMIM:125450
PHARMGKB IDPA137
Map Location4q13.3

GO terms in DCK


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
CC IDA GO:0005634 nucleus
CC IBA GO:0005737 cytoplasm
CC TAS GO:0005829 cytosol
BP IDA GO:0006220 pyrimidine nucleotide metabolic process
BP IEA GO:0009157 deoxyribonucleoside monophosphate biosynthetic process
BP IEA GO:0009165 nucleotide biosynthetic process
Showing 1 to 6 of 16 rows rows per page

Gene expression in normal tissue: DCK

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in DCK


Loading, please wait...
Database
Pathway ID
Pathway Des.
kegg hsa00230 Purine metabolism - Homo sapiens (human)
kegg hsa00240 Pyrimidine metabolism - Homo sapiens (human)
pharmgkb PA165860384 Lamivudine Pathway, Pharmacokinetics/Pharmacodynamics
pharmgkb PA2036 Gemcitabine Pathway, Pharmacodynamics
humancyc PWY-7199 pyrimidine deoxyribonucleosides salvage
humancyc PWY-7200 superpathway of pyrimidine deoxyribonucleoside salvage
Showing 1 to 6 of 17 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD353 PD0325901 1
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in DCK

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​